共 50 条
- [32] Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design Advances in Therapy, 2019, 36 : 3059 - 3070
- [35] Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1189 - 1191
- [36] Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis BMC PULMONARY MEDICINE, 2015, 15